Vor Biopharma (VOR) Assets (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Assets data on file, last reported at $506.7 million in Q1 2026.

• Quarterly Assets rose 363.58% year-over-year to $506.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $506.7 million (up 363.58% YoY) and the FY2025 annual result came in at $464.1 million, up 224.81% from the prior year.
• Assets climbed to $506.7 million in Q1 2026 per VOR's latest filing, from $464.1 million in the prior quarter.
• Across five years, Assets topped out at $506.7 million in Q1 2026 and bottomed at $109.3 million in Q1 2025.
• The 5-year median for Assets is $206.4 million (2022), against an average of $232.0 million.
• The widest annual swing landed in 2024, when Assets plunged 47.99%; it then jumped 363.58% in 2026.
• Tracing VOR's Assets over 5 years: stood at $299.4 million in 2022, then plunged by 33.82% to $198.1 million in 2023, then dropped by 27.88% to $142.9 million in 2024, then jumped by 224.81% to $464.1 million in 2025, then gained by 9.18% to $506.7 million in 2026.
• Per Business Quant, the three latest VOR Assets figures stand at $506.7 million (Q1 2026), $464.1 million (Q4 2025), and $176.2 million (Q3 2025).

Peer Comparison